BrainStorm Cell Therapeutics (NASDAQ:BCLI) CMO Dr. Ralph Kern sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco.
BrainStorm Cell Therapeutics halfway through enrolling its Phase 3 ALS study
Upcoming Events
June 17-19, 2019
July 08-10, 2019
Jan 12, 2020
Jan 13-15, 2020
Jan 13-15, 2020
